By Cristina Roca 
 

Roche Holding AG (ROG.EB) said Monday that the chief executive of its Roche Pharmaceuticals business is leaving at the end of the year, and named his successor.

The Swiss pharmaceuticals company said current CEO Daniel O'Day will step down as of Dec. 31, and said it was appointing William Anderson to the post effective Jan. 1.

Roche said Mr. Anderson will also become a member of its corporate executive committee.

Mr. Anderson is currently chief executive of Genentech, a Roche subsidiary company. He has worked for Roche since 2006.

Separately, Roche said it was proposing Hans Clevers for election to its board of directors. Mr. Clevers is a professor of molecular genetics at University Medical Center Utrecht, the company said.

 

Write to Cristina Roca at cristina.roca@dowjones.com; @_cristinaroca

 

(END) Dow Jones Newswires

December 10, 2018 01:35 ET (06:35 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Roche (QX) Charts.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Roche (QX) Charts.